Anantha Koteswararao Kanugula

Principal Scientist, Discovery & Gene Therapy @Apellis Pharmaceuticals

Boston, MA, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Apr 2023 — Present

Principal Scientist, Discovery & Gene Therapy @Apellis Pharmaceuticals

View department →

Waltham, MA, US

EDUCATION

2003 — 2005

Sri Ramachandra Institute Of Higher Education and Research

Masters, Biotechnology

N/A

Jawaharlal Nehru Technological University, Hyderabad

PhD, Biotechnology

ABOUT ANANTHA KOTESWARARAO KANUGULA

Extensive experience with pre-clinical and cell-based assay method development to evaluate the potency of small molecules, and bispecific antibody-coupled cytokines. • Skilled at identifying, validate and define therapeutic concepts for targets, elucidating mechanisms of action, assessing target engagement and move forward drug discovery programs. • Hands-on experience with developing robust in vitro models with engineered and primary cell lines for cell-based assays.• Hands-on experience with lipid based nucleic acid delivery and generation and maintenance of lentiviral-mediated stable cells.• Direct experience with biological assays (multi color flow cytometry, qPCR, Immuno-cyto, histochemistry, etc.) and proficiency in molecular biology skills.• Highly collaborative project team leadership with cross-functional impact to advance discovery and development pipeline across multiple therapeutic areas.• Manage, mentor, self-motivation, and have the ability to work independently, develop, conduct performance reviews, and drive goal setting and development planning.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Anantha Koteswararao Kanugula — Principal Scientist, Discovery & Gene Therapy at Apellis Pharmaceuticals in Boston, MA, US | Unifers